Clovis Oncology, Inc. (CLVS)

NASDAQ: CLVS · IEX Real-Time Price · USD
0.829
0.048 (6.10%)
At close: May 16, 2022 4:00 PM
0.830
0.001 (0.096%)
After-hours:May 16, 2022 7:58 PM EDT
Market Cap119.30M
Revenue (ttm)144.95M
Net Income (ttm)-258.42M
Shares Out143.88M
EPS (ttm)-2.29
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,577,296
Open0.800
Previous Close0.782
Day's Range0.761 - 0.860
52-Week Range0.700 - 7.240
Beta1.67
AnalystsSell
Price Target3.06 (+269.0%)
Earnings DateMay 4, 2022

About CLVS

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the company offers Rubraca for recurrent epithelial ovarian, fallopian tube, or primary peritoneal canc...

IndustryBiotechnology
IPO DateNov 16, 2011
CEOPatrick Mahaffy
Employees413
Stock ExchangeNASDAQ
Ticker SymbolCLVS
Full Company Profile

Financial Performance

In 2021, CLVS's revenue was $148.76 million, a decrease of -9.58% compared to the previous year's $164.52 million. Losses were -$264.52 million, -28.35% less than in 2020.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for CLVS stock is "Sell." The 12-month stock price forecast is 3.06, which is an increase of 269.03% from the latest price.

Price Target
$3.06
(269.03% upside)
Analyst Consensus: Sell
Stock Forecasts

News

2 Biotech Stocks That Could Go Parabolic

These gems are hiding in a sector that has been pummeled so far this year.

Other symbols:AXSM
16 hours ago - The Motley Fool

Why Clovis Oncology Stock Was Plummeting This Week

Investors bailed from the company after a quarterly results and operational update.

1 week ago - The Motley Fool

Clovis Oncology to Present at the BofA Securities 2022 Healthcare Conference

BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--Clovis Oncology to Present at the BofA Securities 2022 Healthcare Conference

1 week ago - Business Wire

Clovis (CLVS) Q1 Loss Wider than Expected, Revenues Miss

Clovis (CLVS) incurs wider-than-estimated loss for first-quarter 2022. Sales of the sole marketed drug Rubraca decline year over year due to COVID-19 impacts.

1 week ago - Zacks Investment Research

Clovis Oncology (CLVS) Reports Q1 Loss, Lags Revenue Estimates

Clovis (CLVS) delivered earnings and revenue surprises of -2.33% and 7.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

Clovis Oncology Announces First Quarter 2022 Operating Results and Provides Update on Clinical Development Programs

BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--Clovis Oncology Announces First Quarter 2022 Operating Results and Provides Update on Clinical Development Programs

1 week ago - Business Wire

Clovis Oncology Highlights Rubraca® (Rucaparib) and FAP-2286 Data to be Presented at 2022 ASCO Annual Meeting

BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--Clovis Oncology Highlights Rubraca® (Rucaparib) and FAP-2286 Data to be Presented at 2022 ASCO Annual Meeting

2 weeks ago - Business Wire

Clovis Oncology (CLVS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Clovis (CLVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 weeks ago - Zacks Investment Research

Clovis Oncology to Announce First Quarter 2022 Financial Results and Host Webcast Conference Call on May 4

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology to Announce First Quarter 2022 Financial Results and Host Webcast Conference Call on May 4

3 weeks ago - Business Wire

Why Clovis Oncology Stock Fell 10.5% on Monday

Clovis' shares dropped early in the day then rallied.

4 weeks ago - The Motley Fool

Clovis Oncology Highlights Presentations on FAP-2286 and Rubraca® (Rucaparib) at the AACR Annual Meeting 2022

BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--Clovis Oncology Highlights Presentations on FAP-2286 and Rubraca® (Rucaparib) at the AACR Annual Meeting 2022

1 month ago - Business Wire

Best Penny Stocks to Watch After the Stock Market Takes a Bear Turn

Can these penny stocks continue to climb after a bearish trading day? The post Best Penny Stocks to Watch After the Stock Market Takes a Bear Turn appeared first on Penny Stocks to Buy, Picks, News and ...

Other symbols:ADMAADTX
1 month ago - PennyStocks

Clovis (CLVS) Up 24% on Upbeat Data From Ovarian Cancer Study

Clovis Oncology's (CLVS) stock price rises after it reports favorable data from a late-stage study on Rubraca as the first-line maintenance treatment of ovarian cancer.

1 month ago - Zacks Investment Research

Trading Penny Stocks & What You Need to Know in April

What you need to know about trading penny stocks in April The post Trading Penny Stocks & What You Need to Know in April  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks...

Other symbols:CEIHUSN
1 month ago - PennyStocks

Top Penny Stocks To Buy Under $5? 4 Short Squeeze Stocks To Watch Now

Short squeeze stocks to watch in April The post Top Penny Stocks To Buy Under $5? 4 Short Squeeze Stocks To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:GEVOGFAIREI
1 month ago - PennyStocks

Why Clovis Oncology Stock Skyrocketed 80% This Week

Positive data regarding its lead drug boosted the company's shares.

1 month ago - The Motley Fool

Clovis Oncology News: Why CLVS Stock Is Roaring Higher Today

Clovis Oncology (CLVS) stock is in the news Thursday as shares rocket higher thanks to positive data from a recent clinical trial. The post Clovis Oncology News: Why CLVS Stock Is Roaring Higher Today a...

1 month ago - InvestorPlace

Clovis Oncology's Rubraca Significantly Improves PFS In Ovarian Cancer Regardless Of Biomarker Status

Clovis Oncology Inc (NASDAQ: CLVS) announced positive topline data from the monotherapy arm of Phase 3 ATHENA-MONO trial of Rubraca (Rucaparib) as first-line maintenance treatment in ovarian cancer. Rub...

1 month ago - Benzinga

Trading Penny Stocks? Top Stock Market News for March 31st, 2022

Here's what you need to know about trading penny stocks on March 31st The post Trading Penny Stocks? Top Stock Market News for March 31st, 2022 appeared first on Penny Stocks to Buy, Picks, News and Inf...

Other symbols:DAREFWBI
1 month ago - PennyStocks

Why Clovis Oncology Stock Is Soaring Today

Clovis Oncology Inc (NASDAQ: CLVS) is trading higher Thursday morning after the company announced data from the monotherapy arm of the ATHENA trial achieved the primary endpoint of significantly improve...

1 month ago - Benzinga

Clovis Oncology to seek FDA approval for ovarian cancer drug as a maintenance therapy

Shares of Clovis Oncology Inc. CLVS, -3.51% soared 40.0% in premarket trading on Thursday after the company said its drug, Rubraca, improved survival when used as a maintenance treatment for women with ...

1 month ago - Market Watch

Clovis Oncology's Rubraca® (Rucaparib) Significantly Improves Progression-Free Survival in First-line Maintenance Tre...

BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--Clovis Oncology's Rubraca® (Rucaparib) Significantly Improves PFS in First-line Maintenance Treatment in Women with Ovarian Cancer ...

1 month ago - Business Wire

Why Is Clovis (CLVS) Down 14.8% Since Last Earnings Report?

Clovis (CLVS) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

Clovis Oncology and Evergreen Theragnostics Initiate Development and Manufacturing Services Agreement for Actinium-22...

BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--Clovis Oncology and Evergreen Theragnostics Initiate Development and Manufacturing Services Agreement for Actinium-225-Labeled FAP-2286

2 months ago - Business Wire

Hot Penny Stocks to Watch Next Week? 3 For Your List

Which penny stocks are on your watchlist for next week? The post Hot Penny Stocks to Watch Next Week?

Other symbols:ATOSEOSE
2 months ago - PennyStocks